Such modern and emerging therapies include: Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), and functional neurosurgical procedures.
In addition to VNS, psychiatic neurosurgical treatments, offered in conjunction with the Departments of Neurosurgery and Neurology at MGH, include both ablative (lesion) procedures (such as, anterior cingulotomy, limbic leucotomy, and anterior capsulotomy, collectively termed "limbic system surgery [LSS]") and non-ablative methods using deep brain stimulation (DBS).
At this time, the principal indications for these types of device-based treatments include major mood disorders (as indications for ECT, VNS, LSS) and obsessive compulsive disorder (as an indication for LSS). It should be emphasized that, at this time, DBS remains an experimental treatment for both mood disorders and obsessive compulsive disorder.
Of note, transcranial magnetic stimulation (TMS) represents another emerging experimental device-based treatment for severe resistant psychiatric disorders.
The MGH Somatotherapies Unit provides assessment, treatment and follow-up in the context of ECT and VNS. The MGH Psychiatric Neurosurgical Committee reviews all cases referred for ablative procedures and DBS. Treatment and research with respect to these neurosurgical procedures is carried out in a coordinated fashion with oversight by the Psychiatric Neurotherapeutics Program and The Psychiatric Neurosurgical Committee.
MGH Somatotherapies Unit
Electroconvulsive Therapy (ECT) - Michael E. Henry, MD, Director of ECT
Vagus Nerve Stimulation (VNS) - Darin Dougherty, M.D., Director of VNS
Ned Cassem, M.D.
Darin Dougherty, M.D.
Alice Flaherty, M.D., Ph.D.
Bruce Price, M.D.
Phone: (617) 726-3407
Public Transportation Access: yes
Disabled Access: yes
Coordinator, Psychiatric Neurosurgery Committee
Massachusetts General Hospital
15 Parkman St.
Boston, MA 02114
Discover the largest hospital-based research program in the U.S. and how clinicians and scientists chart new terrain in biomedical research to treat and prevent human disease and bring the latest advances to patient care